EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The impact of age on ablation outcomes in AF‐mediated cardiomyopathy

Louise Segan, David Chieng, Hariharan Sugumar, Aleksandr Voskoboinik, Liang-Han Ling, Ben Costello, Sonia Azzopardi, Ziporah Nderitu, Ramanathan Parameswaran, John Amerena, Alex J McLellan, Geoffrey Lee und 7 weitere

Journal of Cardiovascular Electrophysiology · 2023

DOI: 10.1111/jce.16052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2023. Verfasst von Louise Segan und 18 weiteren Autor:innen. Beteiligte Einrichtung: The Baker Heart and Diabetes Research Institute, Melbourne, Australia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiomyopathies, Heart Failure, Systolic, Catheter Ablation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The absence of ventricular scar in patients with atrial fibrillation (AF) and systolic heart failure (HF) predicts left ventricular (LV) recovery following AF ablation. It is unknown whether age impacts the degree of LV recovery, reverse remodeling, or AF recurrence following catheter ablation (CA) among this population.

Objectives

To evaluate the impact of age on LV recovery and AF recurrence in a population with AF and systolic HF without fibrosis (termed AF‐mediated cardiomyopathy) following CA.

Methods

Consecutive patients undergoing CA between 2013 and 2021 with LV ejection fraction (LVEF) < 45% and absence of cardiac magnetic resonance imaging (CMR) detected LV myocardial fibrosis were stratified by age ( .05) albeit a higher CHADS 2 VASc score in the older cohort (2.7 ± 0.9 vs. 1.6 ± 0.6 age < 65, p < .001). Freedom from AF was comparable (hazard ratio: 0.65, 95% confidence interval: 0.38–1.48, LogRank p = .283) as was AF burden [0% (interquartile range, IQR: 0.0–2.1) vs. age ≥ 65: [0% (IQR 0.0–1.7), p = .516], irrespective of age. There was a significant improvement in LV systolic function in both groups (ΔLVEF + 21 ± 14% vs. +21 ± 12% age ≥ 65, p = .913), with LV recovery in the vast majority (73% vs. 69%, respectively, p = .759) at 13 (IQR: 12–16) months. This was accompanied by comparable improvements in functional status (New York Heart Association class p = .851; 6‐min walk distance 50 ± 61 vs. 93 ± 134 m in age ≥ 65, p = .066), biomarkers (ΔN‐terminal‐pro brain natriuretic peptide −139 ± 246 vs. −168 ± 181 age ≥ 65, p = .629) and HF symptoms (Short Form‐36 survey Δphysical component summary p = .483/Δmental component summary, p = .841).

Conclusion

In patients undergoing CA for AF with systolic HF in the absence of ventricular scar, comparable improvements in ventricular function, symptoms, and freedom from AF are achieved irrespective of age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiomyopathiesHeart Failure, SystolicCatheter AblationHeart FailureHumansFemaleAgedMaleCicatrixVentricular Function, LeftMyocardiumStroke VolumeFibrosisTreatment Outcome

Stichwörter der Autor:innen

AF-mediated cardiomyopathyatrial fibrillationcatheter ablationelderlyheart failuremyocardial fibrosis

Autor:innen und Institutionen

  • The Baker Heart and Diabetes Research Institute, Melbourne, Australia.
  • The Alfred Hospital, Melbourne, Australia.
  • University of Melbourne, Melbourne, Australia.
  • Cabrini Hospital, Melbourne, Australia.
  • Western Health, Melbourne, Australia.
  • Royal Melbourne Hospital, Melbourne, Australia.

ORCID-Profile: Joseph Morton, Jonathan M Kalman, Peter M Kistler

Zitieren

APA

Segan, L., Chieng, D., Sugumar, H., Voskoboinik, A., Ling, L. H., Costello, B., Azzopardi, S., Nderitu, Z., Parameswaran, R., Amerena, J., McLellan, A. J., Lee, G., Morton, J., Joseph, S., Wong, M., Taylor, A., Kalman, J. M., Kistler, P. M., & Prabhu, S. (2023). The impact of age on ablation outcomes in AF‐mediated cardiomyopathy. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16052

Vancouver

Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, et al. The impact of age on ablation outcomes in AF‐mediated cardiomyopathy. Journal of Cardiovascular Electrophysiology. 2023. doi:10.1111/jce.16052

BibTeX
@article{Segan2023,
  author = {Segan, Louise and Chieng, David and Sugumar, Hariharan and Voskoboinik, Aleksandr and Ling, Liang-Han and Costello, Ben and Azzopardi, Sonia and Nderitu, Ziporah and Parameswaran, Ramanathan and Amerena, John and McLellan, Alex J and Lee, Geoffrey and Morton, Joseph and Joseph, Stephen and Wong, Michael and Taylor, Andrew and Kalman, Jonathan M and Kistler, Peter M and Prabhu, Sandeep},
  title = {The impact of age on ablation outcomes in AF‐mediated cardiomyopathy},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2023},
  doi = {10.1111/jce.16052}
}
Kostenlos starten →